↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$860KSold on the market
1Companies
Sep 1, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 202619:08 | Sep 1, 2026 | ALKSAlkermes plc. | EVP R&D, Chief Medical Officer | S · Sell10b5-1 | $46.99 | −9,000 | 65,389 | -12% | −$423K | ||
| Sep 1, 202619:08 | Sep 1, 2026 | ALKSAlkermes plc. | EVP R&D, Chief Medical Officer | M · Exercise10b5-1 | $24.59 | +5,000 | 74,389 | +7% | $123K | ||
| Aug 3, 202619:12 | Aug 3, 2026 | ALKSAlkermes plc. | EVP R&D, Chief Medical Officer | S · Sell10b5-1 | $48.58 | −9,000 | 69,389 | -11% | −$437K | ||
| Aug 3, 202619:12 | Aug 3, 2026 | ALKSAlkermes plc. | EVP R&D, Chief Medical Officer | M · Exercise10b5-1 | $24.48 | +5,000 | 78,389 | +7% | $122K |